SPDR Gold Trust vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? SPDR Gold Trust trades at $382.79 (market cap $139.66B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.43 (market cap $6.04B). The key difference: SPDR Gold Trust is far larger — about 23.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| GLD | IOVA | |
|---|---|---|
Market Cap | $139.66B | $6.04B |
Volume | 9,544,773 | 14,805,993 |
52-Week High | $495.90 | $14.82 |
52-Week Low | $362.32 | $1.81 |
Typical Hold Time | 74 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $5.97B |
Signals from Pluang's Aura AI — not financial advice
GLD is trading at $375.88, down 1.66% over the past 24 hours amid broader market pressure from rising Treasury yields and Federal Reserve policy uncertainty. The technical picture remains bearish with moving averages and oscillators signaling continued downward momentum, while key support levels cluster around $372-375. Recent news highlights gold's struggle to maintain gains despite weak economic data, with prices testing critical support zones.
The outlook for GLD remains challenged by persistent headwinds from elevated yields and dollar strength, though some analysts see tactical buying opportunities at current levels. Key risks include further Fed tightening and deteriorating technical momentum, while potential catalysts include sustained inflation concerns and geopolitical tensions that could revive safe-haven demand.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →